Travere Therapeutics, Inc.
2020 Q4 - 2025 Q4 (21 filings)
Shares History
History scope: non-option holdings only (PUT/CALL rows excluded).
| All 13F Holders | Filing date | Value ($000s) | % of Holdings | Shares | Reporting period |
|---|---|---|---|---|---|
| 2025 Q4 | 2/12/2026 | 9,536 | 0.0% | 249,557 | 12/31/2025 |
| 2025 Q3 | 11/3/2025 | 665 | 0.0% | 27,814 | 9/30/2025 |
| 2025 Q2 | 10/8/2025 | 412 | 0.0% | 27,814 | 6/30/2025 |
| 2025 Q1 | 10/8/2025 | 411 | 0.0% | 22,914 | 3/31/2025 |
| 2024 Q4 | 10/8/2025 | 399 | 0.0% | 22,914 | 12/31/2024 |
| 2024 Q3 | 10/8/2025 | 321 | 0.0% | 22,914 | 9/30/2024 |
| 2024 Q2 | 10/8/2025 | 211 | 0.0% | 25,614 | 6/30/2024 |
| 2024 Q1 | 10/8/2025 | 197 | 0.0% | 25,591 | 3/31/2024 |
| 2023 Q4 | 10/8/2025 | 231 | 0.0% | 25,662 | 12/31/2023 |
| 2023 Q3 | 10/8/2025 | 230 | 0.0% | 25,768 | 9/30/2023 |
| 2023 Q2 | 10/8/2025 | 812 | 0.0% | 52,871 | 6/30/2023 |
| 2023 Q1 | 10/8/2025 | 1,343 | 0.0% | 59,731 | 3/31/2023 |
| 2022 Q4 | 10/8/2025 | 1,219 | 0.0% | 57,951 | 12/31/2022 |
| 2022 Q3 | 11/8/2022 | 1,429 | 0.0% | 57,977 | 9/30/2022 |
| 2022 Q2 | 8/4/2022 | 1,047 | 0.0% | 43,218 | 6/30/2022 |
| 2022 Q1 | 7/1/2022 | 1,117 | 0.0% | 43,339 | 3/31/2022 |
| 2021 Q4 | 2/2/2022 | 1,344 | 0.0% | 43,284 | 12/31/2021 |
| 2021 Q3 | 11/2/2021 | 954 | 0.0% | 39,339 | 9/30/2021 |
| 2021 Q2 | 8/2/2021 | 739 | 0.0% | 50,654 | 6/30/2021 |
| 2021 Q1 | 5/11/2021 | 1,156 | 0.0% | 46,300 | 3/31/2021 |
| 2020 Q4 | 2/8/2021 | 1,262 | 0.0% | 46,300 | 12/31/2020 |